We are Rosemont

We’re proud to have been a speciality pharmaceutical leader in liquid medicines for over 50 years.

Rosemont was established in 1967 by two pharmacists in response to the lack of liquid medicines available for their patients who couldn’t swallow tablets or capsules.

We have since continued to bring liquid medicines to market and advocate support for vulnerable patients with swallowing difficulties. In 1974, our first liquid medicine was granted a license from the MHRA. We have subsequently continued our commitment to research, developing more liquid medicines to support both healthcare professionals and their patients. We now have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products.

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practices for the care of patients with swallowing difficulties.

Rosemont advocates the use of liquid medications over manipulating solid dose medications, like crushing tablets. We have a range of educational materials designed for healthcare professionals, which focus on key patient groups and their medication management challenges.

Rosemont has over 50 years of expertise in the development, manufacture and distribution of oral liquid medicines. Our state-of-the-art manufacturing site in Leeds (West Yorkshire, UK) has had significant investment and seen considerable expansion over the years.

We now produce over 4 million bottles of liquid medicine every year. The commitment to ensuring we have the latest technologies within our production and warehousing facilities serves to enhance our capabilities and capacity. We will continue to adapt and remain flexible to ensure that we meet the needs of the NHS, healthcare professions and the patients they care for.